Treatment of Finger Infection
For a finger infection, initiate immediate surgical incision and drainage combined with empiric oral amoxicillin-clavulanate 875/125 mg twice daily, which provides optimal coverage against Staphylococcus aureus, streptococci, and anaerobes commonly implicated in these infections. 1
Immediate Surgical Management
Surgical drainage is the cornerstone of treatment and must not be delayed. 1 The infected area requires:
- Incision and drainage with the wound left open to allow continued drainage rather than primary closure 1
- Copious irrigation of the wound cavity to remove purulent material and debris 1
- Cautious debridement of any necrotic or devitalized tissue 1
- Deep tissue cultures obtained via biopsy or curettage after debridement (avoid superficial swabs as they are unreliable) 1
Empiric Antibiotic Therapy
First-Line Oral Regimen
Amoxicillin-clavulanate 875/125 mg twice daily is the preferred empiric oral agent, providing comprehensive coverage against the most common pathogens in finger infections 1, 2. This combination offers:
- Excellent activity against S. aureus (methicillin-susceptible), streptococci, and gram-negative organisms 2
- Anaerobic coverage essential for contaminated wounds 2
- High strength of evidence supporting its use 1
Alternative for Penicillin Allergy
Clindamycin 300 mg three times daily serves as the primary alternative for penicillin-allergic patients 1, 3. This agent provides:
- Good activity against staphylococci, streptococci, and anaerobes 1
- Moderate strength of evidence 1
- Dosing should be taken with a full glass of water to avoid esophageal irritation 3
When to Add MRSA Coverage
If MRSA is suspected based on local prevalence, previous MRSA infection, or lack of clinical improvement after 48-72 hours, add one of the following 1:
- Trimethoprim-sulfamethoxazole 160-800 mg twice daily (oral option with high efficacy) 1
- Linezolid 600 mg twice daily (oral option, more expensive with more side effects) 1
- Vancomycin 30 mg/kg/day IV in 2 divided doses (for severe infections requiring hospitalization) 1
Hospitalization and IV Therapy
For moderate to severe infections requiring hospitalization, use ampicillin-sulbactam 1.5-3.0 g IV every 6-8 hours 1. This provides:
- Broad-spectrum coverage similar to oral amoxicillin-clavulanate 1
- High strength of evidence for hospitalized patients 1
Treatment Duration
Continue antibiotics for 1-2 weeks for mild infections and 2-3 weeks for moderate to severe infections 1. Key principles include:
- Therapy should continue until resolution of infection signs (decreased erythema, swelling, pain, drainage) 1
- Antibiotics need not continue until complete wound healing 1
- Reassess within 2-5 days for outpatient management to ensure clinical improvement 1
Critical Adjunctive Measures
Tetanus Prophylaxis
Ensure tetanus prophylaxis if not received within 10 years, with Tdap preferred over Td if not previously administered 1, 2. This is particularly important for:
Antibiotic Adjustment
Modify antibiotic therapy based on culture results and clinical response 1. If no improvement occurs despite appropriate antibiotics:
- Consider surgical re-exploration for inadequate drainage or undrained collections 1
- Reassess for resistant organisms or alternative diagnoses 1
- Evaluate for deeper extension (tenosynovitis, osteomyelitis, septic arthritis) 4
Common Pitfalls to Avoid
- Never rely on antibiotics alone without adequate surgical drainage - this is the most common cause of treatment failure 1
- Do not obtain superficial wound swabs - they are unreliable and often grow contaminants rather than true pathogens 1
- Avoid premature wound closure - the wound must remain open for drainage until infection resolves 1
- Do not delay treatment beyond 3 hours - this significantly increases infection risk and complications 2
Special Considerations for Contaminated Wounds
For finger infections from contaminated sources (soil, organic matter, wood splinters), the broad coverage of amoxicillin-clavulanate is particularly important 2. These wounds carry risk of: